Archynetys Live news trend intelligence
▲ Peaking Business

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

GLP-1 weight loss drug usage in the United States has reached a record high, with 11% of Americans currently taking medications such as Wegovy.

5sources
5articles
3velocity
+0%since first seen
57m agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

Usage of GLP-1 weight loss drugs has hit a new peak in the U.S. Recent data indicates that 11% of the population is currently using these medications.

Coverage from The Washington Post, The New York Times, and Gallup News emphasizes that Americans are taking these drugs in record numbers. Forbes reports that this increase in usage coincides with a drop in the U.S. obesity rate.

Future developments involve the ongoing growth of GLP-1 usage and its continued impact on national obesity rates.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 55m ago.

Quick answers

What percentage of Americans are taking GLP-1 drugs?

According to Gizmodo, 11% of Americans are currently taking a GLP-1 weight loss drug like Wegovy.

What is the reported effect on U.S. obesity rates?

Forbes reports that the U.S. obesity rate is dropping as GLP-1 usage grows.

Which outlets are reporting on this trend?

The trend is being covered by The Washington Post, Forbes, Gallup News, The New York Times, and Gizmodo.

Coverage (5)

Topics

Related trends

▲ Peaking Health

Wegovy weight loss pill now available in UK

The UK has launched the first daily oral GLP-1 weight management pill, Wegovy, now available via high street and online pharmacies.

5 sources 5 articles v 3 7h ago